Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 71335-1675

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 71335-1675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351675)

Label for Tramadol ER 100 mg (CIV) extended release oral tablets, packaged by Bryant Ranch Prepack in Burbank, CA. The label includes storage instructions to keep at 20°-25°C and keep out of reach of children. It also compares the product to Ultram ER 100 mg tablets from Sun Pharma Industries Ltd. The label shows an NDC of 71335-1675-1 and a package count of 30 tablets.*

FDA Label Image

Tramadol-figure1 (Tramadol Figure1)

A line graph comparing plasma concentration over 24 hours of Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Immediate-Release Tablets 50 mg every six hours. The graph plots Tramadol concentration (ng/mL) on the vertical axis against time (hours) on the horizontal axis, showing concentration changes for both formulations over time.*

FDA Label Image

Tramadol-figure2 (Tramadol Figure2)

A line graph comparing M1 concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (solid circles) and Tramadol IR Tablets 50 mg every 6 hours (open circles). The x-axis represents time in hours, and the y-axis represents M1 concentration levels.*

FDA Label Image

Tramadol-figure3 (Tramadol Figure3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various response thresholds for different doses of tramadol hydrochloride extended-release tablets (100 mg, 200 mg, 300 mg, 400 mg) and placebo. The x-axis represents response threshold as percent improvement from baseline, and the y-axis shows percent of patients achieving the response.*

FDA Label Image

Tramadol-figure4 (Tramadol Figure4)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis' showing the percentage of patients achieving various levels of response thresholds expressed as percent improvement from baseline. It compares response rates between Tramadol Hydrochloride Extended-Release Tablets and placebo, illustrating higher percentages of responders across response thresholds for the Tramadol group.*

FDA Label Image

Tramadol-structure (Tramadol Structure)

Chemical structure diagram of tramadol hydrochloride showing its molecular framework including aromatic ring, cyclohexane ring, hydroxyl, methoxy, and dimethylamino functional groups, with the hydrochloride indicated separately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.